The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al.

Ähnliche Einträge

• The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al.
  von: Haiyan Zhou, et al.
  Veröffentlicht: (2020-10-01)
• Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy
  von: Zhou, Haiyan, et al.
  Veröffentlicht: (2020)
• Comment on: “Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy” by Zhou et al.
  von: Chen, Tai‐Heng
  Veröffentlicht: (2020)
• Antisense Oligonucleotides for the Treatment of Spinal Muscular Atrophy
  von: Porensky, Paul N., et al.
  Veröffentlicht: (2013)
• Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy
  von: Catapano, Francesco, et al.
  Veröffentlicht: (2016)